(3) A parallel comparison between TAAs and AFP was performed and led to the conclusion that anti-TAA autoantibodies are produced earlier in sera than AFP, indicating that a panel of anti-TAA autoantibodies could be promising biomarkers in the early detection of HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.